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1. Introduction 
Cancer constitutes a major problem in animal pathology and is a subject of intensive 
research. The aim of this study was to gain comprehensive knowledge of cancer biology. 
Some animal tumors are also considered good research models in comparative oncology. 
Literature and own studies show that dogs often suffer from skin cancer and mammary 
gland tumors (Moulton, 1990). The incidence of mammary gland tumors in female canines is 
second only to skin cancer (Misdorp & Meuten, 2002; Ramalho et al, 2006). They most 
commonly appear between 6 and 10 years of age (Misdorp & Meuten, 2002; Hampe & 
Misdorp, 1974; Kubiak, 200). There are also documented cases of such tumors as early as at 
the age of two years and, very rarely, in males (Moulton, 1990). Histopathological 
examination in about 40-50% of cases shows malignant tumors, most of which are of 
epithelial origin (Rutteman, 2001). These cancers originate from epithelial follicles or ducts 
and take forms of papillary adenocarcinomas, simple or complex tubular and solid cancers 
(Misdorp & Meuten, 2002). There are also tumors derived from myoepithelial cells and 
mesenchymal tissue. In veterinary medicine there is a constant search for  prognostic factors 
and predictors that allow for proper evaluation of the disease state, survival, susceptibility 
to treatment and risk of relapse. Recognized factors are: age of the animal, sentinel lymph 
node status, histological type of tumor and a histological grade of differentiation of 
malignancy. Beside the fundamental method in cancer diagnosis, which is the 
histopathological examination, additional information useful in this regard is provided by 
research on cancer biology, including, among others, the study of tumor markers. In 
histological examination of a tumor, markers of proliferative activity such as mitotic index, 
thymidine labeling index, percentage of cells in the S phase of cell cycle, expression of 
nuclear antigen Ki-67  and proliferating cells nuclear antigen (PCNA) are also taken into 
account. The following factors are also examined: expression of estrogen receptors, growth 
factor receptors such as: epidermal growth factor receptor (EGFR), insulin growth factor 
receptor (IGFR), growth hormone (GH),markers of high risk of metastasis: plasminogen 
activator and cathepsin D, oncogenes and tumor suppressor genes: c -erbB-2, c-myc, p53, 
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BRCA-1, BRCA-2, markers of tumor angiogenesis, and heat shock proteins (Koda et al, 2004; 
Niwińska, 1995; Olszewski, 1994). Diagnosis of neoplasms of the mammary gland in canines 
does not usually pose a problem, but in some cases there may be difficulties. Targeted 
diagnostic immunohistochemistry using a panel of antibodies makes it easier to determine the 
correct diagnosis. Difficulties encountered during routine diagnosis of neoplasms of the 
mammary gland  in female dogs relate to assessing the origin of the tumor and its biology. 
Immunophenotyping can be helpful in the diagnostic process and tumor markers (expression 
of nuclear antigen Ki-67 and expression of estrogen receptors and the p53 protein) carry useful 
information, but determination of malignancy is still based on morphological criteria, such as 
mitotic index, which together with the histopathological criteria are the most important factors 
differentiating benign tumors from those of malignant nature;. In veterinary oncology there is 
a constant search for new tumor markers that could aid in differential diagnosis of mammary 
gland neoplasms in female canines. The aim of research on the mammary gland neoplasms in 
female dogs is to extend the panel of tumor markers by addition of new markers such as COX-
2, P-gp, Hsp90 and Hsp70 and  to incorporate them into routine diagnostics. Occurrence of 
mammary tumors in females as well as potential to use canine models in comparative 
pathology of these tumors makes it an interesting research material. It is known that the 
degree of malignancy is positively correlated with proliferative activity. Relationship between 
the expression of estrogen receptors and the degree of malignancy is not entirely clear, 
although most authors believe that expression of these receptors is greater in benign tumors. 
COX-2 is expressed in many canine tumors such as canine kidney, bladder, prostate, and 
mammary gland cancers, but there is no data on the relationship between expression of COX-2 
and other markers, even though such relation would seem logical because the expression of 
COX-2 may be related to prognosis by indirect immunosuppressive effect and inhibition of 
apoptosis. Literature on the expression of heat shock protein or glycoprotein - P in breast 
cancer is very scarce. There is evidence of Hsp27, Hsp70 and Hsp90, as well as glycoprotein – 
P expression, which may influence susceptibility to  therapy. One would expect a correlation 
between proliferative activity, degree of malignancy and expression of estrogen receptors, but  
no data is available on such relationship. The aim of the study was to analyze the role of 
classical and new tumor markers in the histopathological differential diagnosis of mammary 
gland neoplasms in female dogs. The objective of the present study was to investigate the 
expression of cyclooxygenase - 2 and heat shock proteins in canine mammary gland tumors 
and their correlations with histological type of tumor, degree of its histological malignancy, 
proliferative activity, estrogen receptor expression, infiltration by cells, as well as P-gp and p53 
protein expression. 
2. Materials, methods and results 
2.1 Materials 
Material for the investigation comprised 133 tumor samples of the mammary gland 
collected from female canines during surgical procedures performed at Warsaw Veterinary 
Clinics and Small Animal Clinic of the Department of Clinical Sciences, Faculty of Vetrinary 
Medicine, Warsaw University of Life Sciences – SGGW. Tumor samples were fixed in 8% 
formalin buffered with phosphates. After 24h fixing, material was dehydrated in a series of 
increasing concentrations of alcohol and embedded in paraffin. Paraffin blocks were cut into 
serial sections of 4µm in thickness.  
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2.2 Methods 
Then, they were stained using proper methods. In sections stained with the routine H&E 
method, the following determinations were carried out: type of neoplasm (Misdorp et al, 
1999), tumor grade including tubule formation, intensity of division and the degree of 
neoplastic cell differentiation (Misdorp & Meuten, 2002), mitotic index defined as a mean 
number of mitoses in neoplastic cells counted in 10 fields of vision at the lens magnification 
of 400x (surface field 0.17mm2). Paraffin sections on slides covered with 2% saline solution 
in acetone, at the temperature of 420C were used for immunohistochemical methods. In 
immunohistochemical reactions, the following antibodies, properly diluted in 1% BSA 
(Sigma), were used: mouse monoclonal antibody against human nuclear antigen Ki-67 
(Dako) diluted 1:75 (Nieto et al, 2000), mouse monoclonal antibodies against p53 (Dako) 
human protein, diluted  at a ratio 1:25 (Gamblin et al, 1994; Rodo, 2007), mouse monoclonal 
antibodies against alpha (Dako) human estrogen receptor, diluted at a ratio 1:35 (Mulas et al, 
2005), mouse monoclonal antibodies against COX-2 (Dako) human receptor, diluted  at a 
ratio 1:100 (Queiroga et al, 2007; Doré et al, 2003; Soslow et al, 2000), mouse monoclonal 
antibodies against Hsp70 (Novocastra) human heat shock proteins, diluted at a ratio 1:40 
(Romanucci et al, 2006), mouse monoclonal antibodies against Hsp90 (Novocastra) human 
heat shock proteins, diluted at a ratio 1:40 (Romanucci et al, 2006 ) and mouse monoclonal 
antibodies against P-glycoprotein (Sigma), diluted at a ratio 1:100 (Petterino et al, 2006). 
Sections were deparafinized in xylene and rehydrated in increasing concentrations of 
alcohol. Then, they were placed in a buffer with a pH of 6 (Dako). In order to uncover the 
antigen epitope, sections were warmed up in a microwave oven (1x5 min at 600 W, 2x5 min 
at 300 W). Then, they were cooled for 20 min. After two washings in distilled water  (5 min), 
slides were washed in TRIS-buffered saline with pH of 8 (Sigma) and incubated with the 
primary antibody for 1h at room temperature. Then, the preparations were washed with 
TRIS buffer for 10 min. The En Vision + TM System (Dako) was used for visualization. After 
30 min of incubation with reagent, the slides were washed with TRIS buffer and a solution 
of diaminobenzidine (DAB, Dako), prepared according to the procedure supplied by the 
producer, was put on slides. The degree of slide staining was controlled. They were washed 
in tap water and stained with Ehrlich hematoxylin for 5 min, contrasted in 1% acid alcohol 
and washed again in tap water. Then, slides were dehydrated in graded alcohol 
concentrations, passed through xylene and fixed in DPX mounting medium (Gurr®). 
Computer image analysis and Lucia v. 4.21 software were used for  interpretation of the 
results of Ki-67, ER, p53, COX-2, Hsp70, Hsp90 expression; using those facilities we could 
count the number of neoplastic cells featuring stained cytoplasm per 1,000 neoplastic cells. 
Results were analyzed using the SPSS 12.0 program. To determine whether differences for a 
few independent traits were significant, Kruskal-Wallis test was used. This test is an 
equivalent to the test of variance for traits without normal distribution. Two-sided 
correlations were performed using Spearman correlation test. The differences were deemed 
statistically significant at P ≤ 0.05. 
2.3 Results 
Investigated material contained 14 adenomas (Fig.1), 66 complex carcinomas 
(adenocarcinomas), 47 simple carcinomas (adenocarcinomas) (Fig. 2, Fig. 3) and 6 solid 
carcinomas. The number of cancers with a defined grade amounted to, respectively, 1st 
grade –  48, 2nd grade – 39 and  3rd grade – 32. Mammary gland neoplasms were excised from 
female dogs belonging to 18 breeds in the ages between 3 and 16 years. 
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Fig. 1. Adenoma, H&E method  x 20 
 
Fig. 2. Adenocarcinoma simplex, H&E method x 20 
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Fig. 3. Adenocarcinoma simplex, H&E (40x). The following mature tissues are visible: 
pathologic mitotic figures  
2.3.1 Relationship between age of bitches and the grade of malignancy and 
histological type of tumor of epithelial origin 
Dogs were divided into three age groups: <8 years, 8 -12 years and >12 years. In the group 
of bitches below the age of 8, majority (61.1%) consisted of tumors with the lowest 
histological grade of malignancy (1st). In the oldest group,  1st and 2nd grade tumors in the 1st 
and 2nd accounted for 77.8%. In the entire pool of studied tumors in all age groups, the 
largest share consisted of tumors with the lowest degree of histological malignancy (40.4%) 
(Table 1). Assessment of the contribution of individual types of tumors at different ages 
showed that in bitches younger than 8 years  the most common findings were adenomas 
(21.7%) and complex carcinomas (56.5%) and in those over 12  years simple carcinomas 
occurred most often (55.0%) (Table 2). 
 
Age of bitches 
Tumor grade Total 
Io IIo IIIo  
<8 lat (n=18) 11 (61,1%) 3 (16,7%) 4 (22,2%) 18 
8-12 lat (n=83) 30 (36,0%) 29 (35,0%) 24 (29,0%) 83 
>12 (n=18) 7 (38,9%) 7 (38,9%) 4 (22,2%) 18 
total (n=119) 48 (40,4%) 39 (32,8%) 32 (26,8%) 119 
Table 1. Incidence of malignancies of various grades in bitches in different age groups 
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Age of bitches 
Types of tumors 
Total 
Adenoma
Carcinoma 
solidum 
Adenocarcinoma 
simplex 
Adenocarcinoma 
complex 
<8 lat 5 (21,7%) 1 (4,3%) 4  (17,4%) 13 (56,5%) 23 
8-12 lat 7 (7,8%) 4 (4,4%) 32  (35,6%) 47 (52,2%) 90 
>12 lat 2 (10,0%) 1 (5,0%) 11 (55,0%) 6 (30,0%) 20 
Total 14 (10,5%) 6 (4,5%) 47 (35,3%) 66 (49,6%) 133 
Table 2. Occurrence of individual types of epithelial neoplasms in different age groups in 
bitches 
2.3.2 Results of proliferative activity 
The value of mitotic index differed significantly between types of tumors. The lowest 
proliferative activity was observed in adenomas, the highest in simple and solid carcinomas. 
The highest proliferative activity was found in tumors in the 3rd grade of malignancy, the 
lowest in the tumors in the 1st grade (Fig.4). Expression of Ki-67 protein was observed in the 
nuclei of neoplastic cells that have undergone division (Fig.5). Statistical analysis shows 
significant differences between particular types of tumors. The lowest number of cells 
exhibiting Ki-67 protein expression was observed in adenomas, the highest in the solid and 
simple carcinomas and in tumors with the highest histological grade of malignancy (3rd). 
 
 
Fig. 4. Average number of cells showing Ki-67 expression depending on the tumor grade. 
Letters (a, b, c) above the columns show that the differences between mean values were 
statistically significant (P≤0.05).  
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Fig. 5. Adenocarcinoma simplex, expression of  Ki-67, immunohistochemical method. (40x) 
2.3.3 Results of cellular infiltration in tumors of epithelial origin 
In most cases, infiltrates were located predominantly in the stroma at the periphery of the 
tumor, and, in rare cases, occurred in the glandular alveoli. Inflammatory infiltrates 
consisted of lymphocytes, neutrophils and macrophages. The intensity of cellular infiltration 
was assessed on a four-level scale::   -/+;  +;  ++;  +++. Statistical analysis indicates no 
correlation between the age of the dog and the intensity of cellular infiltration in the tumor. 
It is worth noting that, in bitches between the ages of 8 to 12 years, most tumors exhibited 
the intensity of infiltration at the first (+) level  , which constituted 50% of tumors in this age 
group. A significant relationship was found  between the intensity of cellular infiltration and 
the type of tumor. In 50% of solid cancers, there was no cellular infiltration. Only 33% of 
these tumors exhibited the presence of cellular infiltration at the first level (+), and 16.7% on 
the second level (++). Among the complex cancers, the largest group consisted of those, in 
which cellular infiltration was found at the first (+) and the second (++) level. The highest 
average intensity of cellular infiltration was found in complex carcinomas, followed by 
simple carcinomas, adenomas and solid carcinomas. Specific differences were seen between 
adenomas and complex carcinomas (P=0.007) and between solid carcinomas  and complex 
carcinomas (P=0.005). While examining the relationship between intensity of cellular 
infiltration and histological grade of malignancy, no significant differences were revealed. 
But it may be noted that among tumors of all histological grades of malignancy, the largest 
group consisted of cancers with the first level of cellular infiltration. While analyzing the 
average intensity of cellular infiltration in tumors with various histological grades of 
malignancy  no significant differences were found between groups with the exception of the 
tumors in the 3rd grade, where a significant difference was observed (P=0.023). 
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2.3.4 Results of p53 expression in neoplasms of mammary gland 
Expression of p53 protein was observed in the nuclei of cancer cells (Fig.6). Positive reaction 
of p53 protein was observed in 70 (52.6%) of all tumors. Expression of p53 protein was 
found in 4 adenomas. The largest group of tumors positive for p53 protein were complex 
and simple cancers. Solid cancers belonged to a group, which rarely exhibited a positive 
reaction for nuclear p53. Analysis of the average number of cells with a positive reaction for 
p53 showed its highest expression in the case of complex cancers, as well as in 1st and 2nd 
grade tumors (Fig.7). The lowest level of expression of p53 protein was found in adenomas.  
 
Fig. 6. Adenocarcinoma simplex, expression of  p53, immunohistochemical method. (40x) 
No statistically significant differences were shown between the examined groups. 
Comparing the ages of bitches, the highest average number of cells expressing p53 protein 
was found in tumors excised from younger dogs. However, there were no statistically 
significant differences among the age groups. 
2.3.5 Results of estrogen receptor expression in neoplasms of mammary gland 
Estrogen receptor expression was detected in the nuclei of tumor cells, but it was also seen 
in the cytoplasm. Cytoplasmic reaction was considered to be nonspecific. Among all tumors 
of epithelial origin, expression of estrogen receptors was found in 54 (40.6%) , and no 
reaction was noted in 79 (59.4%). Expression of estrogen receptors was most commonly 
found in complex cancers (43.9%) (Fig.8) , followed by simple cancers (42.6%) (Fig.9, Fig.10) 
and adenomas (28.6%), while solid cancers rarely expressed them (16.7%). The highest 
expression of estrogen receptors was found in simple carcinomas as well as in 3rd grade 
tumors, but no statistically significant differences were found between study groups (Fig. 
11). Analysis of the average number of cells showing positive expression of estrogen 
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receptors reveals that the level of expression increases with the histological grade of 
malignancy. It was also found that most tumors expressing estrogen receptors came from 
dogs younger than 8 years. A positive correlation was found between mitotic index and 
expression of estrogen receptors in specific types of cancer and statistically significant 
differences between tumor characteristics were demonstrated (P=0.042). 
 
Fig. 7. Average number of cells showing p53 expression depending on the tumor grade. 
 
Fig. 8. Adenocarcinoma complex, expression of ER, immunohistochemical method. (40x)       
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Fig. 9. Adenocarcinoma simplex, expression of ER, immunohistochemical method. (100x) 
 
Fig. 10. Adenocarcinoma simplex, expression of ER, immunohistochemical method. (100x) 
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Fig. 11. An average number of cells showing ER expression depending on the tumor grade 
2.3.6 Results of cyclooxygenase-2 expression in neoplasms of mammary gland 
Expression of cyclooxygenase – 2 was observed in the neoplastic cell cytoplasm. It was 
confirmed in 13 of 14 adenomas. Similar results were obtained in  solid cancers (5 of 6) (Fig. 
12). Positive COX–2  reaction was found in 36.9% of simple carcinomas (Fig.13). Of all tumors, 
which exhibited a positive response (122), complex tumors demonstrated the highest 
percentage (48.4%). Statistical analysis, however, failed to demonstrate any significant 
differences regarding the COX–2 expression between the individual types of carcinoma (P = 
0.978). According to the analysis of histological malignancy grades, the highest expression was 
found in 3rd grade cancers and statistical significance was confirmed for the individual 
histological malignancy grades (P = 0.047) (Fig. 14, Fig. 15). Furthermore, higher COX-2 
expression level was demonstrated in carcinomas with higher mitotic index; statistical analysis 
demonstrated highly significant differences between neoplasms with high versus low mitotic 
index (P = 0.009) (Fig.16). The investigation into the relationship between expression of Ki-67 
nuclear antigen and the COX–2 expression level did not reveal statistical significance (P = 
0.614) (Fig. 17). Analysis of the relationship between the p53 protein expression and COX–2 
expression level demonstrated a statistically significant correlation between these features (P = 
0.034) (Fig. 18). An average number of cells expressing p53 protein was higher in carcinomas 
with higher COX–2 expression. In addition, experiments explored the relationship between 
Hsp70 protein and cyclooxygenase – 2 expression levels. The study proved a statistically high 
correlation between the investigated neoplastic characteristics (P = 0.006). The lowest Hsp70 
protein expression was found in carcinomas exhibiting second degree COX–2 expression (Fig. 
19). Analysis of the relationship between representative neoplastic features demonstrated 
statistically significant, positive correlations between COX–2 expression, mitotic index (P = 
0.009) and p53 protein expression (P = 0.003); on the other hand, no correlation was found with 
regard to the Ki-67 nuclear antigen expression (P = 0.686). There was no correlation between 
the estrogen receptor expression and the above mentioned parameters. The highest expression 
of estrogen receptors was found in simple cancer types. 
www.intechopen.com
 
A Bird's-Eye View of Veterinary Medicine 
 
210 
 
Fig. 12. Carcinoma solidum, expression of COX–2, immunohistochemical method. (100x) 
 
Fig. 13. Adenocarcinoma simplex, expression of COX–2, immunohistochemical method. 
(100x)    
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Fig. 14. Average number of cells exhibiting COX-2 expression depending on the tumor 
grade.  
 
 
Fig. 15. Average level of COX-2 expression depending on tumor grade. Letters (a, b, c) above 
the columns show that the difference between means was statistically significant (P≤0,05). 
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Fig. 16. Average value of mitotic index in tumors with different degrees of expression of 
cyclooxygenase – 2. Letters (a, b, c, d) above the columns show that the difference between 
means was statistically significant (P≤0.05). 
 
 
Fig. 17. Average number of cells expressing Ki-67, depending on the degree of expression of 
cyclooxygenase – 2. 
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Fig. 18. Average number of cells expressing p53, depending on the degree of expression of 
cyclooxygenase – 2. Letters (a, b) above the columns show that the difference between 
means was statistically significant (P≤0.05). 
 
Fig. 19. Average number of cells expressing Hsp70, depending on the degree of expression 
of cyclooxygenase – 2. Letters (a, b) above the columns show that the difference between 
means was statistically significant (P≤0.05). 
2.3.7 Results of P-glycoprotein expression in neoplasms of the mammary gland 
Expression of P-glycoprotein was identified in cytoplasm and cell membranes of neoplastic 
cells. Positive reaction was found in 76% of all neoplasms. Complex carcinomas were the 
biggest group among cancer types, which demonstrated positive reaction to P-gp. In terms 
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of histological malignancy grade, the most numerous were cancers featuring the lowest 
grade of malignancy (Fig. 20). In female canines aged 9 through 12 years, cancers exhibiting 
a positive P-gp reaction constituted the most numerous group (63.2%); on the other hand, 
this cancer type barely appeared in the oldest group (10.5%). Analysis of the average P - 
glycoprotein expression in different types of carcinomas did not reveal any significant 
differences. Correspondingly, evaluation of malignancy grade showed no statistical 
significance between examined features. Among different cancer types, the highest P-gp 
expression was demonstrated in solid carcinomas and cancers featuring the highest  
histological grade of malignancy. Positive correlation between investigated cancer features 
was found in the analysis of the relationship between cyclooxygenase-2 and P-gp 
expression, where P value was equal to 0.021. 
 
Fig. 20. Average expression level of P–gp depending on the tumor grade.  
2.3.8 Results of heat shock protein expression in neoplasms of mammary gland  
Heat shock proteins were found in the cytoplasm and nuclei of cancer cells (Fig. 21, Fig. 
22, Fig. 23, Fig. 24). The largest group of tumors exhibiting Hsp70 and Hsp90 expression 
included simple and complex cancers, whereas solid tumors were the least numerous 
group. Grade 1 and 2 cancers constituted the largest group expressing both Hsp70 and 
Hsp90 (Fig. 25, Fig. 26) . Immunohistochemical analysis showed high expression of Hsp90 
in simple and complex cancers, but no statistically significant differences were found 
between investigated types of tumors (P=0.443). High expression of Hsp90 was confirmed 
in solid cancers and, in this particular group, significant differences were found between 
types of tumor (P=0.032). As far as grading was concerned, no statistically significant 
differences were found between the mean number of cells exhibiting Hsp70 and Hsp90 
protein expression and malignancy grade. When comparing the expression of Hsp70 to 
the expression of Hsp90 in particular types of cancers, we found a highly significant 
statistical difference (P=0.005) between the expression of both proteins. Results of a study 
on the expression of heat shock proteins (Hsp70 and Hsp90) were compared to nuclear 
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antigen Ki-67 expression. It was found that the expression of nuclear antigen Ki-67 was 
most pronounced in solid tumors, as was the expression of Hsp90. Also, in neoplasms of 
the highest grade, expression of nuclear antigen Ki-67 and protein Hsp90 was the highest. 
High expression of Hsp70 was found in tumors with grade 1 and 3 of cyclooxygenase-2 
expression, whereas the lowest Hsp70 expression was observed in tumors with grade 2 of 
cyclooxygenase-2 expression. Statistical significance was found between the investigated 
features of neoplasms (P=0.009). Increased expression of cyclooxygenase-2 was observed 
in tumors with a low mean number of cells showing positive immunohistochemical 
reaction for protein Hsp90. The highest level of expression of this protein was confirmed 
in tumors with grade 1 of cyclooxygenase-2 expression (Fig. 27). Between the mean 
number of cells showing positive Hsp90 reaction and cyclooxygenase-2 expression, there 
was a statistical significance observed for grade 1 and 2 of cyclooxygenase-2 expression 
(P=0.039). Statistical analysis proved a correlation between  Hsp70 and  p53 protein  
expression in tumors of epithelial origin. High statistical significance was shown for 
investigated neoplastic features (P = 0.002). Taking into account the type of tumor, 
expression of both proteins was highest in complex carcinomas and tumors with the 
lowest histological grade. High expression levels of Hsp90 protein and Ki-67 nuclear 
antigen was shown in cases of solid carcinomas and in carcinomas exhibiting 3rd 
histological grade of malignancy, described by a low apoptotic index.  
 
 
Fig. 21. Adenoma, expression of Hsp70, immunohistochemical method. (20x) 
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Fig. 22. Adenocarcinoma simplex, expression of Hsp70, immunohistochemical method. (100x) 
 
Fig. 23. Adenocarcinoma complex, expression of Hsp70, immunohistochemical method. 
(100x)     
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Fig. 24. Adenocarcinoma complex, expression of Hsp90, immunohistochemical method. 
(10x) 
 
 
 
 
Fig. 25. Average number of cells showing Hsp70 expression depending on the tumor grade.  
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Fig. 26. Average number of cells showing Hsp90 expression depending on the tumor grade 
 
Fig. 27. Average number of cells expressing Hsp90, depending on the degree of 
cyclooxygenase – 2 expression. Letters (a, b) above the columns show that the difference 
between means was statistically significant (P≤0.05). 
3. Discussion and conclusion 
3.1 Discusion 
In our study, cancers accounted for 89.8% of tumors of epithelial origin. This is consistent 
with the results of some authors, although the results of studies on the incidence and 
types of tumors of the mammary gland in canine females given by various authors differ. 
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Löhr (1997) found that 50% of the mammary gland tumors in female canines are 
malignant tumors (Löhr  et al, 1997). Hellmén (1993) determined the incidence of 
malignant tumors to be 68% (Hellmén et al 1993). There are also studies showing, that 
about a half of tumors are benign (Bostock et al, 1992; Gilbertson et al, 1983). Moulton 
(1990) believes that benign tumors represent about 80% of cases and the majority of 
tumors studied are “benign mixed tumors” (65%) (Moulton, 1990). They are tumors in 
which, apart from epithelial and mesenchymal tissue, there is also cartilage and bone 
tissue. Their histopathological examination reveals no sign of malignancy. Nerurkar 
(1990) says that benign tumors represent about 27% of the mammary gland tumors in 
female dogs (Nerurkar et al, 1990). In our study, benign tumors of epithelial origin 
accounted for only 10.1% of all cases. The diversity of these results relates to the lack of 
uniform diagnostic criteria and lack of uniform classification of tumors of the mammary 
gland in dogs. In human medicine, age is a very important prognostic factor. Detection of 
breast cancer in women at a very young age and at the age over 60 is associated with 
worse prognosis (Host & Lund, 1986). In Philibert’s (2003) studies there were no 
significant differences in survival of young and older dogs  (Philibert et al, 2003). Hellmén 
(1993) presented completely different results (Hellmén et al, 1993). She found that age 
may be an important prognostic factor and showed that older bitches had a shorter 
survival time after surgery. Results obtained by Benjamin corresponded to that (1999) 
(Benjamin et al, 1999). Own results support the concept of age as an important prognostic 
factor, as there is very little information regarding survival or recurrence of malignancy in 
female dogs after surgery. Current study shows that the presence or absence of cellular 
inflammatory infiltrates may be a prognostic factor. Data on the incidence of cellular 
infiltration in mammary gland tumors in female dogs is also scarce. Gilbertson (1983) 
found that cell infiltration plays a role in the process of development of precancerous and 
invasive carcinomas (35%) (Gilbertson et al, 1983). In our study, the percentage of tumors 
with cellular infiltration was higher (88%). The highest intensity of cellular infiltration 
was observed in tumors with a high histological grade of malignancy. Skrzypczak (2004) 
(Skrzypczak, 2004) presented similar results in his study . Authors believe that presence of 
cellular infiltration plays a positive role in inhibiting tumor growth. Some studies have 
shown that presence of cellular infiltration is associated with good (Rilke et al, 1991) or 
poor (Parl & Dupont, 1982) prognosis and others, that it carries no prognostic value. In 
our study, no relationship was found between cellular infiltration and other tumor 
markers, consistent with the studies by Rodo (2007) (Rodo, 2007; Roses et al, 1982). It is 
worth noting the presence of necrosis in tumor foci, which may obscure the accuracy of 
the results. Necrosis in the tumor is the result of disparities between high proliferative 
activity and tumor vascularization. It may trigger cellular inflammatory reactions. We 
also analyzed the distribution of cellular infiltration. Our own results differ from the 
results of other authors, because infiltration was observed in the stroma, not scattered 
(Lee et al, 1996), and was more pronounced on the periphery of the tumor. The role of 
cellular infiltration within the tumor remains unclear and controversial. Estrogen 
receptors are recognized markers in the diagnosis of breast cancer in women. It is 
estimated that about 70-80% of breast cancers in women exhibit the expression of estrogen 
receptors. These tumors are characterized by slower growth, higher diversity, better 
prognosis with a suitable treatment regimen and correlate with the length of survival after 
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surgical removal (Bacus et al, 1989; Barzanti et al, 2000). Study of the expression of 
estrogen receptors in  mammary gland neoplasms in female canines was, as usual, 
inconclusive. Martin et. al (1984) studied 228 tumors of the mammary gland in bitches and 
showed the expression of estrogen receptors in only 2.1% of tumors (Martin et al, 1984). 
Pena et. al (1998), on the other hand, diagnosed 21 cancers with an ongoing inflammatory 
process and found no expression of estrogen receptors (Pena et al, 1998). According to 
Sartin et. al (1992) the greatest chance of long-term survival after surgery  , is associated 
with tumors expressing ER alone or together with  PgR. Indeed, in the absence of ER and 
PgR, researchers observed the shortest period of survival (Sartin et al, 1997). Millanta et. 
al (2005) study on 47 mammary gland neoplasms in bitches reported that ER and PgR 
expression did not correlate with survival or histological parameters of tumors (Millanta 
et al, 2005). Similarly, Sobczak-Filipiak and Malicka (1997) have shown no correlation 
between expression of ER and mitotic index (Sobczak-Filipiak & Malicka, 1997). In our 
study, the expression of estrogen receptors was demonstrated in 40% of the tested tumors. 
The highest expression of estrogen receptors was found in simple carcinomas and tumors 
with the highest histological grade of malignancy. There was a significant correlation 
between mitotic index and expression of estrogen receptors. Nowak (2007) found 
expression of estrogen receptors in only 6% of cancers (Nowak et al, 2007), but Mulas 
(2005) obtained different results- he found that estrogen receptors were expressed in 
benign tumors (Mulas et al, 2005). Similarly, McEwen et. al (1982) have demonstrated the 
expression of estrogen receptors in about  50%  of cases, with a significantly higher levels 
of expression present in benign tumors (McEwen et al, 1982). Results obtained by Nieto et. 
al (2000) are different - they show a correlation between the expression of nuclear antigen 
Ki-67 and estrogen receptors (Nieto et al, 2000). Authors of these studies observed the 
highest levels of ER expression in simple and complex carcinomas, as we did in our study. 
Otherwise, Rutteman (1998), Sartin (1992), and Geraldes (2000), claim that high expression 
of ER is present in adenomas compared to adenocarcinomas, which exhibit a lower level 
of expression of this marker (Sartin et al, 1992; Rutteman et al, 2001; Geraldes et al, 2000). 
Opinions about the value of estrogen receptors as a prognostic factor are divided. Some 
authors consider ER expression a positive factor, but there are also voices postulating it is 
a negative prognostic marker. Interestingly, it seems that in our study, low expression of 
ER negatively correlated with high expression of nuclear antigen Ki-67. It is in agreement 
with the  research done by Peña (1998), who led the study on the mammary gland 
neoplasms in canines (Peña et al, 1998). From our research we conclude, that the 
expression of estrogen receptors may be important in assessment of malignancy, but does 
not show significant correlation with other markers. An important marker of malignancy 
is the proliferative activity. Proper evaluation of proliferative activity of tumor cells is 
crucial for the evaluation of its biological activity and is used in determining the treatment 
of cancer. High mitotic index correlated with tumor size and presence of lymph node 
metastases (Niwińska, 1995; Mirecka et al, 1993). In our study, proliferative activity 
depended on both, the type of tumor and the degree of histological malignancy. The 
highest values of mitotic index were recorded in simple and solid carcinomas and in 
tumors with the highest histological grade of malignancy. Similar results were reported 
for the expression of Ki-67. The highest expression of Ki-67 was seen in solid, simple 
carcinomas and in 3rd grade  tumors. Similar results were obtained by Nieto (2000), who 
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confirmed that the expression of Ki-67 is high in tumors with a higher histological grade 
of malignancy (Nieto et al, 2000). Similar results were obtained by Peña (1998), Giziński 
(2003) and Szczubiał (2002) (Peña et al, 1998; Giziński et al, 2003; Szczubiał & 
Łopuszański, 2002). They studied the expression of nuclear antigen Ki-67 in mammary 
gland tumors in dogs and came to the conclusion that higher expression of Ki-67 is an 
important  prognostic factor and is associated with a higher risk of metastasis, a shorter 
period to recurrence and a shorter overall survival period. The rate of tumor growth is 
influenced by factors related to inhibition of cell cycle and promotion of apoptosis of 
cancer cells., Under physiological conditions it is a function of, among others, p53 gene 
and its protein product. Mutation of the p53 gene plays an important role in the 
uncontrolled proliferation and resistance to apoptosis in cancer cells , leading to 
functional changes in proteins. In dogs, expression of the p53 gene was found in both 
benign (Muto et al, 2000) and malignant (Mayr et al, 1994; Veldhoen et al, 1999) tumors of 
mammary gland. Muto (2000) in his study showed no association between p53 expression 
and histological type of cancer, but claimed that this protein may play an important role 
in carcinogenesis and may be a negative prognostic factor (Muto et al, 2000). Chung-Ho 
(2004) came to a similar conclusion, arguing that the presence ofp53 in tumor cells is 
associated with their malignancy and bad prognosis in mammary gland tumors (Chun-Ho 
et al, 2004). In our study, p53 expression was observed in benign as well as malignant 
tumors. Among all tumors, more than 50% exhibited a positive reaction for 53 protein. It 
contradicts the data obtained in his study by Gamblin (1997), who carried out an analysis 
of 16 adenocarcinomas and found a positive reaction for p53 protein in only 12.5% of 
cases  (Gamblin et al, 1994). In our study, the highest expression of p53 was observed in 
complex carcinomas and in 1st and 2nd grade malignant tumors. These results are 
consistent with the results obtained by Rungsipipata (1999), who found the highest levels 
of p53 expression in simple and complex carcinomas and also showed expression of this 
protein in adenomas (16%) (Rungspipata, 1999). Rodo (2007) obtained results on the 
expression of p53 , stating that there is a positive correlation between proliferative activity 
and the number of cells expressing p53 protein (Rodo, 2007). In our study, we found no 
statistically significant differences between the expression of p53 and  nuclear antigen Ki-
67. Obtained data in part explain why the activation of oncogenes does not always lead to 
uncontrolled proliferation when normal signal transduction leads to stabilization of p53 
and activation of programmed cell death. There is a need for further research in this area, 
because the data in the literature is ambiguous and does not allow for a definite 
conclusion as to the importance of p53 protein and its role in  mammary gland neoplasms. 
Varying results undermine the claim that  a positive reaction for p53 protein would 
predict worse prognosis in cancer and that p53 mutation may be responsible for increased 
proliferation in tumors with advanced malignancy. Research on COX-2 expression in 
canine mammary cancers is scarce (Heller et al, 2005; Nowak et al, 2005; Doré et al, 2003) 
despite it being an attractive and motivating topic. Overexpression of COX-2 is known to 
occur in 56-100% of canine mammary carcinomas (Doré et al, 2003; Millanta et al, 2005; 
Queiroga et al, 2007; Heller et al, 2005; Mohammed et al, 2004), but there is a marked 
variation in the percentage of COX-2-positive tumor cells and the intensity of its 
expression. Doré et. al (2003) did not find any COX-2 expression in four samples of 
normal mammary tissue (Doré et al, 2003), whilst Mohammed et. al (2004) (Mohammed et 
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al, 2004) and Queiroga et. al (2007) (Queiroga et al, 2007) reported expression of COX-2 in 
one of seven and two of four samples of normal mammary glands, respectively. Our own 
research demonstrated that as much as 91.7% of all carcinomas in the study displayed 
COX-2 expression. Doré et.al (2003) obtained similar results: he found a positive COX-2 
reaction in 67% of complex cancers and in 47% of simple carcinomas (Doré et al, 2003). 
Our research demonstrated the highest COX-2 expression in simple cancers and the 
lowest in solid cancers. Similar data were presented by Heller et.al (2005), who found 
COX-2 expression in adenocarcinomas, whereas he failed to detect it in solid carcinomas 
(Heller et al, 2005). Ristimäki et. al (2002) demonstrated the relationship between COX-2 
expression and certain clinical and pathological features of the tumor (Ristimäki et al, 
2002). Her research into mammary gland tumours proved that COX-2 expression was 
positively correlated with tumour size as well as the strength of Ki-67 nuclear antigen 
staining and p53 protein expression. Results of our study are consistent with the results of 
works by Ristimäki et. al (2002) : increased COX-2 expression in carcinomas is related to 
higher mitotic index, i.e. with the proliferating activity (Ristimäki et al, 2002). Expression 
of Ki–67 nuclear antigen was demonstrated in carcinomas exhibiting increased COX-2 
expression, yet research failed to prove the correlation between these markers; On the 
other hand, it proved the existence of statistical correlation between COX-2 expression 
and expression of p53 and Hsp70 proteins. Average number of cells exhibiting p53 protein 
expression was higher in carcinomas with higher levels of COX-2 expression. High 
expression level of Hsp70 protein and COX-2 was shown in carcinomas with the 3rd 
histological grade of malignancy, as described by low apoptotic index. Similar results 
were obtained by Lanza-Jacoby et. al (2004), who conducted her studies on experimental 
animals (Lanza-Jacoby et al, 2006), and by Liu and Rose (1996) who studied the COX-2 
expression in cell cultures (Liu & Rose, 1996). Furthermore, Ristimäki et al (2002) and 
Dempke et al (2001) came to a conclusion that COX-2 promoted the mammary gland 
neoplasm growth, invasive capacity, and probability of metastasis (Ristimäki et al, 2002; 
Dempke et al, 2001). COX-2 expression may be relevant to a number of physiological 
processes within this tissue including proliferative activity, inhibition of apoptosis, 
increased angiogenesis and activation of matrix metalloproteinases (Dempke et al, 2001). 
Mammary physiology is a complex process regulated by hormones, estrogens, 
progesterone, growth hormone, prolactin, and epidermal growth factor (Howlin et al, 
2006). As COX-2 expression is induced by different stimuli including cytokines, 
oncogenes, hormones and growth factors (Thomas et al, 2008), the same factors that 
control mammary growth and differentiation may act as trigger stimuli for COX-2 
expression. The results of our work are consistent with the results obtained by other 
researchers. P-gp expression was discovered in epithelium and neoplasms of 
mesenchymal origin in dogs (Ginn, 1996). Author of these studies argues that 
continuation of this line of research will deliver additional prognostic data. There is a 
small number of works attempting to evaluate the P-gp expression in canine mammary 
cancers. A considerable progress in the investigation into P-gp expression in canine 
mammary cancers was made by Petterino et. al (2006), who attempted to define the P-gp 
expression in mammary gland carcinomas in female canines (Petterino et al, 2006). His 
study covered cases of both malignant and benign neoplasms; Petterino et al (2006) found 
the expression of the examined marker in two test groups and confirmed the statistical 
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significance between the two groups (Petterino et al, 2006). Furthermore, he found that 
simple and complex carcinomas were the most numerous groups among the examined 
cancers and that P-gp expression was absent from the tissues of healthy mammary glands. 
We achieved similar results in our research: we found the P-gp expression in 76% of the 
examined canine mammary cancers. The most numerous groups exhibiting a positive P-
gp immunohistochemical reaction were composed of complex carcinomas (90.9%) and 
simple carcinomas (73%). High expression was found in cancers with the highest 
histological grade of malignancy. Due to fact that there are hardly any works 
investigating into the P-gp expression in canine mammary cancers, we attempted not only 
to confirm the presence of P-gp expression and location, but also to prove the  
relationship between P-gp and other neoplastic markers. Statistical analysis confirmed a 
positive correlation between P-gp and COX-2 expression: it demonstrated a statistical 
significance in the case of examined characteristics (P = 0.021). It is worth mentioning that 
the expression of two markers was significant in carcinomas featuring high histological 
grades of malignancy. Furthermore, P-gp expression was studied in canine lymphomas; 
additionally, attempts were made to conduct studies on carcinomas treated by means of 
chemotherapy; the results were compared with the results obtained in the control group 
of untreated carcinomas. Higher expression was observed in the treated cancer cells. On 
the other hand, increased expression in untreated cancers appears to be a negative 
prognostic factor, given that survival rate shall decrease in such cases (Lee et al, 1996). 
Due to the fact that this line of research has not brought about many works, there are 
several questions and ambiguities concerning the role of P-gp in the process of neoplastic 
genesis and the importance of this factor from the clinical point of view. Additionally, the 
question arises whether, or not P-gp can be classified into the significant prognostic 
marker category. We are not aware of defensive mechanisms of the cells equipped with 
membrane transporters against apoptosis generated by the compounds, that are not pump 
substrates. There are suggestions that the phenomenon may be connected with evacuation 
(pumping out) of a certain important mediator of apoptosis or with the impact of P-gp on 
the intracellular pH (Johnson et al, 1998). Identification of a mechanism of cell resistance 
to apoptosis is a key instrument in selection of suitable therapy. According to studies in 
humans, heat shock proteins may be important predictors of breast cancer (Park & 
Dupont, 1982). There is not much published data in the literature on heat shock protein 
expression in mammary gland tumors of female dogs. The role of these proteins in 
carcinogenesis has not been clearly defined either. Studies have only shown that 
expression of heat shock proteins takes place in canine breast cancers , but the linkage 
between these proteins and other tumor markers was not confirmed. Seymour (1990) 
studied endometrial cancer in women and found that heat shock proteins were useful 
markers in the diagnostics of these tumors (Saymour et al, 1990). Expression of Hsp27 was 
also investigated in breast cancer in women (Ciocca et al, 1993). A relationship between 
the expression of this protein and the degree of differentiation of the tumor cells was 
found. Similar studies were conducted  by Storm (1996), who stated that tumors with 
Hsp27 expression showed a higher histological grade than tumors negative for the 
expression of this protein (Storm et al, 1993). Kumaraguruparan (2006) studied the 
expression of Hsp70 and Hsp90 in breast cancer in women and found a correlation 
between the expression of both proteins and proliferative activity (Kumaraguruparan et 
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al, 2006). He suggested that heat shock proteins are important prognostic factors. Presence 
of Hsp70 was also reported in normal gastrointestinal tissues, but an increased expression 
of this protein was observed in gastrointestinal tumors (Isomoto et al, 2003). Isomoto 
(2003) believed that Hsp70 plays an important role in the degree of cellular differentiation 
in tumors, which would indicate that Hsp70 is an important prognostic factor. Similar 
studies are conducted in veterinary medicine, but to a lesser extent (Isomoto et al, 2003). A 
similar study was conducted by Rommanucci (2005) in mammary gland tumors in female 
dogs (Romanucci et al, 2006). She found Hsp70 and Hsp90 expression in simple and 
complex, as well as solid-type adenocarcinomas. Expression of these proteins was 
observed in the cytoplasm, as well as in the nuclei of tumor cells. Rommanucci (2006), in 
her study of breast cancers in female dogs, has not attempted to verify the possible 
correlations between heat shock proteins and other tumor markers (Rommanucci et al, 
2006). She focused on establishing the degree of protein expression and their localization 
in tumor cells. Basing on the results of her study, the author suggested that these proteins 
may play an important role in the process of carcinogenesis. In our study, Hsp70 protein 
expression was found in 86.4% of tumors, while the expression of Hsp90 was observed in 
66.2% of tumors. The aim of our study was to demonstrate the relationship between the 
expression of heat shock proteins and other prognostic factors. When comparing the 
expression of Hsp70 to the expression of Hsp90 in different types of tumors, we found a 
high statistical significance between the expression of both proteins. Analysis of the 
relationship between the expression of nuclear antigen Ki-67 and the expression of  
heat shock proteins showed that the highest expression of Ki-67 as well as Hsp90  
was present in solid tumors. The highest expression of Hsp90 protein and Ki-67 was  
also found in cancers of the highest histological grades. Based on these data it  
can be concluded that Hsp90 is an important factor, which could be considered a marker 
of malignancy and which may be useful in the diagnostics of cancers. Analysis of the 
results showed high expression of Hsp70 in cancers with grade 1 and 3 of COX-2 
expression; the lowest expression of Hsp70 was found in cancers with grade 2 of COX-2 
expression. Statistical significance of P = 0.009 was found between the expression  
of Hsp70 and expression of COX-2. An increased expression of COX-2 was observed  
in tumors with a low mean number of cells showing positive reaction to Hsp90  
protein. Correlation between the expression of Hsp70 protein and p53 protein in tumors 
of epithelial origin was also confirmed. Based on the analysis of expression of both 
proteins and taking into account the mean apoptotic index, it was found that in cancers 
with the third (the highest) histological grade, expression of p53 protein is significantly 
lower than the expression of Hsp70, and the value of apoptotic index in these cancers was 
the lowest. 
3.2 Conclusions  
Occurrence of mammary tumors in female dogs and their potential use as a model in 
comparative pathology makes it an interesting research material. It is known that the degree 
of malignancy is positively correlated with proliferative activity. The relationship between 
expression of estrogen receptors and the degree of malignancy is not entirely clear, although 
most authors believe that the expression of these receptors is higher in benign tumors. 
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Literature concerning the expression of p53 protein in mammary tumors in canines is scarce. 
It deals only with the expression of p53, but leaves no answers  in respect to the expression 
of other factors that are considered prognostic markers, such as proliferative activity, 
histological grade of malignancy and expression of estrogen receptors. We conclude that 
COX-2 is an important prognostic factor and may be applied as a marker of canine 
mammary neoplasm malignancy, given the fact that higher expression of COX-2 was found 
in adenocarcinomas and in cancers featuring the highest histological malignancy grades in 
comparison to simple adenomas. Obtained results suggest that cyclooxygenase-2 may be a 
prognostic factor, but it requires clinical confirmation. The P-gp expression is also positively 
correlated with the degree of histological malignancy. This suggests a prudent approach to 
decisions concerning chemotherapy. Expression of Hsp90 can be considered as a marker of 
the degree of differentiation and of histological grade of mammary gland tumors in dogs, 
because the highest level of expression was found in solid carcinomas and in cancers 
exhibiting the highest histological grades of malignancy. Hsp70 expression was confirmed, 
but no correlation with other factors was found. This may suggest that Hsp70 is not a useful 
marker in the diagnostics of breast cancers in female dogs. 
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